Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 2 de 2
Filtrar
Más filtros










Base de datos
Intervalo de año de publicación
1.
East Mediterr Health J ; 30(4): 292-299, 2024 May 14.
Artículo en Inglés | MEDLINE | ID: mdl-38808405

RESUMEN

Background: Although hepatitis B is vaccine-preventable, it remains a significant health problem. To the best of our knowledge, this is the first hepatitis B outbreak report from Türkiye. Aims: To investigate the cause of hepatitis B outbreak in a nursing home for the disabled and make recommendations for prevention. Methods: An outbreak of acute hepatitis B was declared in a nursing home for the disabled following the admission of 3 patients from the home in a hospital. Collaborative response was initiated with the Provincial Health Directorate through the Public Health Infectious Diseases Department. We began tracking the infection and monitoring active cases. Audits and controls were carried out to determine the source, establish protection and control measures, and prevent further transmission. Results: Six of the 65 nursing home residents were diagnosed with acute hepatitis B. Four of them had diabetes and their blood glucose levels were monitored for at least 12 months. Two of the patients had received dental treatment in the last 6 months. The frequency of both variables, which may be an indication of the transmission route, was statistically significantly greater in the acute hepatitis B group. All the patients who could be sequenced were identified as genotype D. While 3 patients recovered fully, 2 were diagnosed with chronic hepatitis B and one died due to fulminant hepatitis. Conclusion: Standard routine immunization should be implemented as a preventive measure for acute hepatitis B. Frequent supervision and training on hygiene practices and safety precautions should be conducted for care staff working in collective residential facilities.


Asunto(s)
Brotes de Enfermedades , Hepatitis B , Casas de Salud , Humanos , Brotes de Enfermedades/prevención & control , Masculino , Femenino , Hepatitis B/epidemiología , Hepatitis B/prevención & control , Anciano , Persona de Mediana Edad , Personas con Discapacidad/estadística & datos numéricos , Adulto , Enfermedad Aguda , Anciano de 80 o más Años
2.
Hum Vaccin Immunother ; 18(6): 2092362, 2022 Nov 30.
Artículo en Inglés | MEDLINE | ID: mdl-35797599

RESUMEN

Thanks to immunization strategies, which is a multistakeholder process that includes scientific, political, and nongovernmental organizational pillars, deaths and the risk of severe disease caused by COVID-19 infection are prevented. However, to prevent the losses caused by vaccine hesitancy, it is important to reveal the causes. We aimed to determine the frequency of vaccine hesitancy in individuals registered in the central district of Giresun, Turkey, and to investigate the related factors. In this cross-sectional study, the sample was selected from the population aged over 18 years, who were eligible for COVID-19 vaccination but had not been vaccinated. The systematic sampling method was used to select the participants (n = 422) from a list of the entire population (n = 12,055). The dependent variable was "COVID-19 vaccine hesitancy." Data were analyzed using the SPSS 22 software; descriptive, Chi-square, and logistic regression analyses were conducted. The rate of vaccine hesitancy was 58.9%. Vaccine hesitancy was higher in those who were old, employed, and had not been infected with COVID-19. After being given information, 55.8% of those who hesitated and 12.4% of those who resisted were convinced. Distrust in vaccines was the most frequent cause of vaccine hesitancy (32.5%). It was found that vaccine hesitancy was two times higher in those who had not had COVID-19 [OR = 1.95; 95% CI: 1.13-3.369], and 1.7 times higher in those who were employed [OR = 1.70; 95% CI: 1.06-2.74]. The fight against vaccine hesitancy and resistance must be based on active information, guidance, confidence, and a thorough understanding of the reasons.


Asunto(s)
Vacunas contra la COVID-19 , COVID-19 , Humanos , Adulto , Persona de Mediana Edad , Estudios Transversales , COVID-19/epidemiología , COVID-19/prevención & control , Vacunación , Inmunización
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA
...